文献速递结核与非结核分枝杆菌

肺结核患儿病灶部位的药物浓度

Drug concentration at the site of disease in children with pulmonary tuberculosis.
PubMed 文献 · J Antimicrob Chemother · 2022-01-01

该研究在南非开普敦一家三级医院纳入13例中位年龄8.6个月的行支气管镜或经胸外科淋巴结减压术的复杂性肺结核患儿,用群体药代动力学模型描述药物渗透特征并模拟支气管肺泡灌洗液、匀浆淋巴结及细胞性和坏死性淋巴结病灶的浓度。结果显示异烟肼、利福平和吡嗪酰胺在多数淋巴结区域的渗透低于血浆,乙胺丁醇在组织中蓄积,所研究药物均未能在坏死病灶达到目标浓度。

要点

  • 异烟肼、利福平和吡嗪酰胺在多数淋巴结区域渗透低于血浆。
  • 乙胺丁醇在组织中蓄积。
  • 所研究药物均未能在坏死病灶达到目标浓度。

核心结论

  • 尽管药物渗透特征与成人相似,但儿童血浆暴露低导致除异烟肼外所有药物的病灶部位暴露低。

研究设计与样本

  • 研究纳入13例中位年龄8.6个月的复杂性肺结核患儿,均需行支气管镜或经胸外科淋巴结减压术,来自南非开普敦一家三级医院。
  • 采用药代动力学模型描述药物渗透特征,并模拟支气管肺泡灌洗液、匀浆淋巴结及细胞性和坏死性淋巴结病灶的浓度曲线。

主要发现

  • 异烟肼、利福平和吡嗪酰胺在多数淋巴结区域的渗透低于血浆。
  • 乙胺丁醇在组织中蓄积。
  • 所研究药物均未能在坏死病灶达到目标浓度。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Current TB treatment for children is not optimized to provide adequate drug levels in TB lesions. Dose optimization of first-line antituberculosis drugs to increase exposure at the site of disease could facilitate more optimal treatment and future treatment-shortening strategies across the disease spectrum in children with pulmonary TB. OBJECTIVES: To determine the concentrations of first-line antituberculosis drugs at the site of disease in children with intrathoracic TB. METHODS: We quantified drug concentrations in tissue samples from 13 children, median age 8.6 months, with complicated forms of pulmonary TB requiring bronchoscopy or transthoracic surgical lymph node decompression in a tertiary hospital in Cape Town, South Africa. Pharmacokinetic models were used to describe drug penetration characteristics and to simulate concentration profiles for bronchoalveolar lavage, homogenized lymph nodes, and cellular and necrotic lymph node lesions. RESULTS: Isoniazid, rifampicin and pyrazinamide showed lower penetration in most lymph node areas compared with plasma, while ethambutol accumulated in tissue. None of the drugs studied was able to reach target concentration in necrotic lesions. CONCLUSIONS: Despite similar penetration characteristics compared with adults, low plasma exposures in children led to low site of disease exposures for all drugs except for isoniazid.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Lopez-Varela E, Abulfathi AA, Strydom N, et al. Drug concentration at the site of disease in children with pulmonary tuberculosis. J Antimicrob Chemother. 2022. PMID: 35468189. doi:10.1093/jac/dkac103

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。